Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders

November 30, 2020:

Sigma 1 receptor in treatment for neurodegenerative diseases.

https://www.tandfonline.com/doi/full/10.1080/17460441.2021.1838483?scroll=top&needAccess=true